Piperazine 1 4 acetylphenylsulfonyl 4 1 methyl 1H benzimidazol 2 yl 9CI Supplier & Distributor of CAS#

Piperazine 1 4 acetylphenylsulfonyl 4 1 methyl 1H benzimidazol 2 yl 9CI

Quantity:

add to inquiry

Product Description:

Applications & Uses:

CAS#:

SYNONYM:

FORMULA:

PRODUCT TYPE:

HAZARD:

CATEGORIES:

Pharmaceutical , Organic Intermediate , Specialty Chemicals

Technical Specifications

Piperazine 1-(4-acetylphenylsulfonyl)-4-(1-methyl-1H-benzimidazol-2-yl) is a sophisticated chemical compound known for its prominent role in advanced pharmaceutical and chemical research. This carefully crafted molecule combines the structural complexities of piperazine, benzimidazole, and phenylsulfonyl components, delivering a unique blend ideal for intricate chemical synthesis needs. Its molecular framework is designed for high reactivity and stability, positioning it as a vital intermediate in the synthesis of various medicinal and specialty chemicals. The acetylphenylsulfonyl group enhances the compound''s potential in binding assays and pharmacological studies, while the benzimidazole moiety supports its application in designing compounds with potential therapeutic activities. This compound is essential for research environments focused on innovative drug development and chemical exploration, providing a robust building block for numerous applications in medicinal chemistry. Its specialized composition makes it a valuable asset for scientists dedicated to the forefront of chemical and pharmaceutical innovation.

Details

CAS #

CATEGORIES:

Pharmaceutical , Organic Intermediate , Specialty Chemicals , Specialty Chemicals

Having Trouble Finding A Specific Product?
We Will Find It For You!

GET A QUICK QUOTE NOW

Recent Searches

Trending Now

Markets

Process Point

Process Point, LLC.

500 Office Center Drive, Suite 803
Fort Washington, PA 19034
Phone: 855-453-6208

Email: hello@processpointchem.com

Your Product Inquiry

You have not added any products to your inquiry.

Click Here to search our product database.

Unsent Inquiries: